| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | BDSX Biodesix Inc | Hutton Scott59 | President &CEO | Sell | 3,744 | $1.59 | $5,966.12 | -0.4% | -12.4% | -74.5% | |
| Aug 9, 2024 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 1,778 | $30.03 | $53,391.46 | -2.2% | +27.6% | -6.5% | |
| Aug 8, 2024 | CRL Charles River Laboratories International, Inc. | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 1,780 | $199.36 | $354,860.80 | -7.3% | +6.1% | -26.3% | |
| Aug 8, 2024 | WGS Genedx Holdings Corp. | Opko Health, Inc. | 10% Owner | Sell | 112,994 | $31.54 | $3,563,807.18 | -1.9% | +131.3% | +220.2% | |
| Aug 7, 2024 | VCYT Veracyte, Inc. | Holstein Jens | Director | Sell | 5,000 | $29.00 | $145,000.00 | -7.9% | +32.8% | +2.3% | |
| Aug 7, 2024 | VCYT Veracyte, Inc. | Jones Evan/ Fa70 | Director | Sell | 5,108 | $30.32 | $154,883.24 | -10.2% | +32.8% | +2.3% | |
| Aug 7, 2024 | RVTY Revvity, Inc. | Goldberg Joel S58 | Please See Remarks | Sell | 3,500 | $117.86 | $412,507.46 | -2.5% | +8.9% | -25.2% | |
| Aug 7, 2024 | MTD Mettler Toledo International Inc/ | Vadala Shawn68 | Chief Financial Officer | Sell | 250 | $1,401.00 | $350,250.00 | -4.8% | +2.1% | -8.9% | |
| Aug 7, 2024 | CSTL Castle Biosciences Inc | Stokes Frank70 | Chief Financial Officer | Sell | 10,000 | $25.70 | $256,997.40 | -13.0% | +16.2% | -26.7% | |
| Aug 6, 2024 | WST West Pharmaceutical Services Inc | Green Eric Mark57 | President, CEO And Board Chair | Sell | 30,732 | $304.71 | $9,364,409.18 | -16.0% | +3.4% | -22.1% | |
| Aug 5, 2024 | TWST Twist Bioscience Corp | Werner Robert F.62 | Chief Accounting Officer | Sell | 168 | $39.93 | $6,707.57 | -0.4% | -7.2% | -39.3% | |
| Aug 5, 2024 | TWST Twist Bioscience Corp | Finn Patrick John73 | President And COO | Sell | 2,885 | $39.93 | $115,186.51 | -1.7% | -7.2% | -39.3% | |
| Aug 5, 2024 | TWST Twist Bioscience Corp | Leproust Emily M.77 | Chief Executive Officer | Sell | 5,139 | $39.93 | $205,179.71 | -1.0% | -7.2% | -39.3% | |
| Aug 5, 2024 | TWST Twist Bioscience Corp | Cho Dennis70 | See Remarks | Sell | 709 | $39.93 | $28,307.53 | -0.9% | -7.2% | -39.3% | |
| Aug 5, 2024 | TWST Twist Bioscience Corp | Green Paula69 | SVP Of Human Resources | Sell | 1,137 | $39.93 | $45,395.86 | -1.3% | -7.2% | -39.3% | |
| Aug 1, 2024 | DHR Danaher Corp /de/ | McGrew Matthew66 | EVP &Chief Financial Officer | Sell | 16,172 | $279.84 | $4,525,554.69 | -35.5% | -13.7% | -29.8% | |
| Aug 1, 2024 | DHR Danaher Corp /de/ | Filler Linda58 | Director | Sell | 3,928 | $279.50 | $1,097,876.00 | -8.7% | -13.7% | -29.8% | |
| Aug 1, 2024 | CRL Charles River Laboratories International, Inc. | Foster James C77 | Chairman, President And CEO | Sell | 25,000 | $250.00 | $6,250,000.00 | -11.7% | -25.3% | -31.3% | |
| Aug 1, 2024 | CSTL Castle Biosciences Inc | Oelschlager Kristen M72 | Chief Operating Officer | Sell | 12,989 | $23.06 | $299,502.51 | -4.6% | +49.9% | -36.4% | |
| Jul 31, 2024 | WGS Genedx Holdings Corp. | Opko Health, Inc. | 10% Owner | Sell | 88,839 | $33.50 | $2,976,346.37 | -2.9% | +156.8% | +211.6% | |
| Jul 31, 2024 | TMO Thermo Fisher Scientific Inc. | Casper Marc N59 | Chairman &CEO | Sell | 10,000 | $617.21 | $6,172,098.39 | -1.0% | -10.7% | -23.7% | |
| Jul 31, 2024 | DHR Danaher Corp /de/ | Blair Rainer63 | President &CEO | Sell | 9,007 | $280.00 | $2,521,960.00 | -8.4% | -12.4% | -28.8% | |
| Jul 31, 2024 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 3,104 | $100.89 | $313,170.84 | -2.1% | +21.8% | +30.5% | |
| Jul 30, 2024 | PSNL Personalis, Inc. | Tachibana Aaron68 | CFO And COO | Sell | 742 | $2.97 | $2,203.74 | -0.4% | +65.7% | +79.2% | |
| Jul 30, 2024 | PSNL Personalis, Inc. | Chen Richard70 | Chief Medical Officer And EVP | Sell | 524 | $2.97 | $1,556.28 | -0.4% | +65.7% | +79.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.